The Bayer group has announced plans to expand its operations in Asia, predicting annual sales of over €11bn in the region by 2015.

Management board chairman Dr Marijn Dekkers told delegates at Bayer’s international conference that the company aims to achieve a more than 60% increase in sales in Asia by 2015.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

"We have made capital expenditures of €3.4bn in Asia over the past ten years, creating a basis for outperforming market growth in this region," said Dekkers.

Sales in Greater China are planned to account for some €6bn as Bayer expands its production, distribution network and research facilities in the country over the coming years.

In Asia, Bayer achieved sales of €6.9bn in 2010, including €2.9bn in Greater China, and anticipates further growth in Asia in 2011.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Pharmaceutical Technology Excellence Awards - The Benefits of Entering

Gain the recognition you deserve! The Pharmaceutical Technology Excellence Awards celebrate innovation, leadership, and impact. By entering, you showcase your achievements, elevate your industry profile, and position yourself among top leaders driving pharmaceutical advancements. Don’t miss your chance to stand out—submit your entry today!

Nominate Now